deltatrials
Recruiting NA INTERVENTIONAL NCT04917705

Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies (SCLEROMYOMICS)

Search for Diagnostic and Prognostic Biomarkers (Molecular Signatures) in Systemic Sclerosis and Inflammatory Myopathies by a Multi-OMIC Strategy Integrating a Single Cell Analysis Approach

Sponsor: University Hospital, Strasbourg, France

Conditions Inflammatory Myopathies Systemic Sclerosis
Interventions Collection of biological samples
Updated 4 times since 2021 Last updated: Dec 14, 2021 Started: Nov 25, 2021 Primary completion: Jun 30, 2023 Completion: Jun 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Inflammatory Myopathies and Systemic Sclerosis and is currently actively recruiting participants. University Hospital, Strasbourg, France leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  3. Jan 2022 — Jul 2024 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  4. Sep 2021 — Jan 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Hospital, Strasbourg, France
Data source: University Hospital, Strasbourg, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations